Archive | September, 2012

Bladder Cancer Symptoms Actos Patients Should Watch For

September 28, 2012  |   Posted by :   |   Actos Attorney,Actos Bladder Cancer   |   0 Comments

The FDA has issued warnings that patients taking Actos may be at an increased risk for developing bladder cancer. If you or a loved one have been taking Actos on a long term basis or have been proscribed a high dosage of this medication, you are urged to closely monitor your health for changes and symptoms of bladder […]

Read More »

These Bladder Cancer Symptoms Should Be On Your Radar As An Actos User

September 26, 2012  |   Posted by :   |   Actos Attorney,Actos Side Effects   |   0 Comments

A June 2011 online article at speaks about a possible link between the use of the diabetes drug Actos and an increased risk of developing bladder cancer.  These alarming findings were discovered during clinical trials. The article quotes Dr. David Nathan, of Massachusetts General Hospital, as stating that “there are numerous other choices to treat type 2 diabetes.”  In […]

Read More »

Consumer Reports Urges Consumers to Stay Away From Actos

September 24, 2012  |   Posted by :   |   Actos Lawsuit,Actos Litigation,Actos Side Effects   |   0 Comments

Consumer Reports has recently reported that diabetic patients should avoid using Actos, unless other options have not worked. There are concerns regarding Actos use due to the increased risk for developing bladder cancer among patients that have used Actos.   side effects users of this prescription have experienced. While the FDA has issued warnings about Actos, […]

Read More »

Studies Show Actos, a Diabetes Drug, Increases Risk of Bladder Cancer

September 21, 2012  |   Posted by :   |   Actos Attorney,Actos Bladder Cancer,Actos Side Effects   |   0 Comments

Numerous studies have found definitive evidence linking long-term use of Actos, a diabetes drug, to an increased risk of bladder cancer. For example, in July 2012 a study in the Canadian Medical Association Journal asserted that taking Actos adds a 22 percent risk to the already elevated risk of bladder cancer that diabetes patients experience. Further evidence […]

Read More »